Rosiglitazone protects against renal ischemia-reperfusion-induced lung injury via HMGB1/MYH9-PPARγ pathway
Acute kidney injury can damage far more than the kidneys. When renal blood flow is interrupted and then restored, the resulting ischemia–reperfusion injury can trigger...















